Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Buyers are here

<< Previous

Bullboard Posts

Next >>

Post by Drmrgnon Sep 06, 2023 10:04am

205 Views

Post# 35621713

Buyers are here

THTX volume has almost doubled its average daily volume and it's only 10am! And it's up over 20%! Hoping this means the stock is only up from here but wouldn't mind picking up more in the low $.90s usd. Will be interesting to see if this thing remains in the green by end of the day.

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network